NOVACYT (EPA:ALNOV) | Finanzwire

BRIEF

published on 12/10/2024 at 11:59, 11 days 7 hours ago

Novacyt Announces Relocation of Corporate Headquarters

Global Operations Molecular Diagnostics Corporate Relocation Novacyt Headquarters Genomic Medicine
PRESS RELEASE

published on 12/10/2024 at 11:54, 11 days 7 hours ago

Changement de siège social
Novacyt announces immediate headquarters relocation to 131 Boulevard Carnot, Le Vésinet, France, reinforcing its position as a global molecular diagnostics company

Headquarters Relocation Paris London Molecular Diagnostics Novacyt
PRESS RELEASE

published on 11/14/2024 at 15:31, 1 month 7 days ago

Further expansion of cost reduction programme
Novacyt announces further expansion of cost reduction programme with proposed site consolidations expected to deliver c. £2.0m EBITDA improvement, including closure of Eastleigh site and transfer of Canada manufacturing operations to Manchester

Cost Reduction EBITDA Improvement Manufacturing Operations Novacyt Site Consolidations
BRIEF

published on 11/14/2024 at 15:31, 1 month 7 days ago

Novacyt launches new veterinary tests

Gastrointestinal Diseases Novacyt Molecular Diagnosis Veterinary Tests Pathogens
BRIEF

published on 11/01/2024 at 14:00, 1 month 20 days ago

Novacyt: Update on liquidity contract and voting rights

Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF

published on 11/01/2024 at 13:57, 1 month 20 days ago

Novacyt Updates on Liquidity Agreement and Voting Rights

Liquidity Agreement INVEST SECURITIES Total Voting Rights French Law Novacyt Shares
PRESS RELEASE

published on 11/01/2024 at 13:52, 1 month 20 days ago

Liquidity Agreement and Total Voting Rights
Novacyt provides liquidity agreement update and total voting rights information, with Invest Securities purchasing and selling ordinary shares. Company divided into clinical, instrumentation, and research use segments

Ordinary Shares Liquidity Agreement Total Voting Rights Novacyt Clinical Diagnostics
BRIEF

published on 10/31/2024 at 10:28, 1 month 21 days ago

Dr. Ian Gilham Joins Novacyt as Non-Executive Director

Life Sciences Board Appointment Non-Executive Director Novacyt Dr. Ian Gilham
BRIEF

published on 10/31/2024 at 10:25, 1 month 21 days ago

Appointment of Dr Ian Gilham to the Board of Directors of Novacyt

Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE

published on 10/31/2024 at 10:23, 1 month 21 days ago

Directorate Change
Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board

Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed

1 2 ... 5

Published on 12/21/2024 at 01:30, 17 hours 30 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 30 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 55 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 30 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 9 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 15 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 50 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 43 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News